A new study published in the journal of CNS Drugs showed that low-dose naltrexone (LDN) did not outperform placebo in ...

low-dose naltrexone hydrochloride delayed-release capsules) (“SP-104”), a novel low-dose delayed-release naltrexone hydrochloride being developed for the treatment of fibromyalgia. Scilex ...

Learn about the opioid epidemic and its impact on Black communities. Discover efforts to address the crisis and improve ...

Annual whole-body, low-dose computed tomography (WBLDCT) can improve the management of smoldering multiple myeloma (SMM), according to a study published online March 25 in the Journal of Clinical ...

As side effects are dose-related, the idea of low-dose isotretinoin therapy for less severe forms of acne is attractive, but little data exist on the safety and efficacy of this strategy.

The primary endpoint was the mean normalcy of diet score on the clinician-rated Performance Status Scale for Head and Neck at 1 year. The mean score was 91.6 in the dose-reduction arm and 92.6 in the ...

Ascletis is taking a low and slow approach to oral GLP-1 dose titration in a phase 2a test after getting a look at clinical data. The latest results show a high starting dose, fast titration model ...

Starting oral or injectable naltrexone at hospital discharge reduced heavy drinking in patients with alcohol use disorder. The hospital is an opportune setting for identifying and treating ...

It is a common belief that low-dose dopamine may be helpful in the prevention and treatment of acute renal failure and is being widely used in these situations. Does dopamine have a beneficial ...

But buprenorphine’s strength as a treatment is also a weakness. Buprenorphine is an opioid. Like methadone, the tightly ...

The researchers used the GRADE guidelines to categorize the entire body of evidence (GRADE isn’t applied to individual studies) as either high, moderate, low, or very low. From this, they were ...